A Study of Onapristone ER in Gynecologic Cancers That Respond to Progesterone
Conditions: Granulosa Cell Ovarian Cancer; Low Grade Serous Ovarian/ Primary Peritoneal Cancer; Endometrioid Endometrial Cancer Intervention: Drug: Onapristone ER Sponsors: Memorial Sloan Kettering Cancer Center; Context Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Ovarian Cancer | Ovaries | Peritoneal Cancer | Research | Study